Current Price and Market Context
As of 10 Feb 2026, Aster DM Healthcare Ltd (Stock ID: 1002923) closed at ₹572.00, up from the previous close of ₹563.05. The stock traded within a range of ₹559.90 to ₹573.25 during the day, remaining well below its 52-week high of ₹732.00 but comfortably above the 52-week low of ₹386.15. The company operates within the hospital industry and sector, with a market cap grade of 3, indicating a mid-tier market capitalisation relative to peers.
Technical Trend Evolution
The technical trend for Aster DM Healthcare has transitioned from a clearly bearish phase to a mildly bearish one. This subtle improvement suggests that while downward momentum has eased, the stock has yet to establish a definitive bullish trend. The daily moving averages remain bearish, signalling that short-term price action is still under pressure. However, weekly and monthly indicators provide a more varied outlook.
MACD Analysis
The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly timeframe, indicating that the short-term momentum is still negative. Conversely, the monthly MACD has shifted to mildly bearish, hinting at a potential bottoming process or a slowing of the downtrend over a longer horizon. This divergence between weekly and monthly MACD readings suggests that while short-term traders may remain cautious, longer-term investors might find some comfort in the stabilising momentum.
RSI and Momentum Indicators
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This absence of an overbought or oversold condition implies that the stock is not exhibiting extreme momentum in either direction, reinforcing the notion of a consolidation phase. The KST (Know Sure Thing) indicator presents a bearish reading on the weekly scale but turns bullish monthly, further underscoring the mixed momentum signals.
Bollinger Bands and Price Volatility
Bollinger Bands analysis reveals a mildly bearish stance on the weekly chart, indicating that price volatility remains somewhat elevated with a tendency towards downside pressure. However, the monthly Bollinger Bands are bullish, suggesting that over a longer timeframe, price volatility may be contracting with a potential for upward price movement. This contrast between weekly and monthly Bollinger Band signals highlights the importance of timeframe in technical analysis for this stock.
Volume and Trend Confirmation
On-Balance Volume (OBV) does not indicate a clear trend on the weekly chart but shows a mildly bearish signal monthly. This suggests that volume flow is not strongly supporting a price rally, which is a cautionary sign for investors looking for confirmation of trend reversals. Additionally, Dow Theory analysis reports no trend on the weekly scale and a mildly bearish trend monthly, reinforcing the cautious outlook.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Comparative Returns and Market Performance
Examining Aster DM Healthcare’s returns relative to the Sensex provides further insight into its performance dynamics. Over the past week, the stock returned 2.7%, slightly underperforming the Sensex’s 2.94% gain. The one-month return was negative at -6.77%, contrasting with the Sensex’s modest 0.59% rise. Year-to-date, the stock has declined by 7.18%, while the Sensex fell by 1.36%, indicating relative weakness in the near term.
However, the longer-term picture is more favourable. Over one year, Aster DM Healthcare delivered a robust 20.87% return, significantly outperforming the Sensex’s 7.97%. The three-year and five-year returns are even more impressive at 174.47% and 268.79%, respectively, dwarfing the Sensex’s 38.25% and 63.78% gains. This long-term outperformance highlights the company’s growth trajectory despite recent technical headwinds.
Mojo Score and Analyst Ratings
MarketsMOJO assigns Aster DM Healthcare a Mojo Score of 28.0, categorising it with a Strong Sell grade as of 4 Feb 2026, an upgrade from the previous Sell rating. This downgrade reflects the deteriorating technical and fundamental outlook, signalling caution for investors. The market cap grade of 3 further suggests that the stock is mid-sized relative to its sector peers, which may impact liquidity and volatility.
Technical Summary and Outlook
The overall technical summary for Aster DM Healthcare is one of cautious optimism tempered by persistent bearish signals. The shift from bearish to mildly bearish technical trend indicates some easing of downward pressure, but the daily moving averages and weekly MACD remain negative. The neutral RSI readings and mixed Bollinger Bands suggest a consolidation phase rather than a clear directional move.
Investors should closely monitor the monthly MACD and KST indicators for signs of a sustained bullish reversal. Additionally, volume trends as indicated by OBV and Dow Theory signals will be critical in confirming any change in momentum. Given the stock’s strong long-term returns, a technical rebound could present an attractive entry point, but the current mixed signals warrant a cautious approach.
Holding Aster DM Healthcare Ltd from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Considerations
For investors considering Aster DM Healthcare, the current technical landscape suggests a need for prudence. The stock’s recent price momentum shows tentative signs of stabilisation, but the absence of strong bullish confirmation means that downside risks remain. The company’s strong historical returns and sector positioning in healthcare provide a fundamental cushion, yet technical indicators advise waiting for clearer trend confirmation before committing significant capital.
Monitoring key technical levels such as the 50-day and 200-day moving averages, alongside MACD crossovers and RSI thresholds, will be essential in gauging the stock’s next directional move. Additionally, broader market conditions and sector-specific developments in the hospital industry should be factored into investment decisions.
Conclusion
Aster DM Healthcare Ltd’s technical parameters reveal a stock in transition, with momentum shifting from bearish to mildly bearish amid mixed signals from key indicators. While daily moving averages and weekly MACD remain bearish, monthly indicators offer a glimmer of potential recovery. The stock’s long-term outperformance relative to the Sensex underscores its growth credentials, but near-term caution is warranted given the current technical ambiguity.
Investors are advised to watch for confirmation of trend reversals through volume and momentum indicators before increasing exposure. The company’s strong fundamentals and sector positioning may reward patient investors, but the technical outlook calls for a measured approach in the current market environment.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
